Skip to content
Screener

Microbot Medical MBOT Q2 2025 earnings

Reported August 12, 2025 · Before market open

EPS-$0.10Miss by $0.02
Revenue estimate$630.0K
EPS estimate-$0.08

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$566.7K
EPS estimate-$0.09

Financials

Q2 2025

Income statement

See full
Operating income-$3.7M-48.3%
Net income-$3.5M-42.0%
EPS (diluted)-$0.10+41.2%

Balance sheet

See full
Cash & equivalents$4.1M+64.5%
Total debt$149.0K+0.7%
Total equity$30.4M+401%
Total assets$33.1M+346%

Cash flow

See full
Operating cash flow-$2.6M-31.5%
CapEx$9.0K+125%
Free cash flow-$2.6M-31.7%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$93.13M+472%
Enterprise value$89.15M+540%

Returns & leverage

See full
Return on equity-69.8%-22.7pp
Debt / equity0×0.0×
Current ratio12.1×+6.7×

FAQ

When did Microbot Medical report Q2 2025 earnings?
Microbot Medical (MBOT) reported Q2 2025 earnings on August 12, 2025 before market open.
What were Microbot Medical's Q2 2025 revenue and EPS?
Microbot Medical reported eps of $-0.10 for Q2 2025.
Did Microbot Medical beat estimates in Q2 2025?
EPS missed the consensus estimate of $-0.08 by $0.02.
How did Microbot Medical's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 41.2% from $-0.17.
Where can I find Microbot Medical's Q2 2025 SEC filings?
You can read the 10-Q periodic report (0001641172-25-023206) directly on SEC EDGAR. The filing index links above go to sec.gov.